MARKET

DGX

DGX

Quest Diagnostics Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

141.03
+0.94
+0.67%
After Hours: 141.03 0 0.00% 16:15 05/25 EDT
OPEN
140.47
PREV CLOSE
140.09
HIGH
142.31
LOW
139.70
VOLUME
841.11K
TURNOVER
0
52 WEEK HIGH
174.16
52 WEEK LOW
125.77
MARKET CAP
16.55B
P/E (TTM)
9.40
1D
5D
1M
3M
1Y
5Y
Insider Sell: Quest Diagnostics
MT Newswires · 8h ago
Quest Diagnostics Mobile Unit Coming to New Hampshire
Quest Diagnostics recently purchased a new 24-foot trailer that has been outfitted to serve as a mobile Patient Service Center (PSC). This mobile PSC will bring Quest clinical specimen collection t...
News Direct · 9h ago
Quest Diagnostics CHRO Receives "CHRO Lifetime Achievement Award"
-- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced Cecilia McKenney, Senior Vice President and Chief Human Resources Officer (CHRO), received the "CHRO Lifetime Achievement Award" by SharedXpe...
PR Newswire · 9h ago
Quest Diagnostics Support the American Heart Association HBCU Scholars
We are proud to support the American Heart Association HBCU Scholars. Congratulations to the 50 Scholars who completed this year’s program that concluded with a symposium showcasing their research.
News Direct · 4d ago
Classroom Garden Helps Trotwood Combat Food Insecurity
By Michelle Alfini
News Direct · 6d ago
Quest Diagnostics declares $0.66 dividend
Quest Diagnostics (NYSE:DGX) declares $0.66/share quarterly dividend, in line with previous. Forward yield 1.88% Payable July 20; for shareholders of record July 6; ex-div July 5. See DGX Dividend Scorecard,
Seekingalpha · 05/17 20:55
--Quest Diagnostics Maintains Quarterly Dividend at $0.66 a Share, Payable July 20 to Shareholders as of July 6
MT Newswires · 05/17 16:55
We Like Quest Diagnostics' (NYSE:DGX) Returns And Here's How They're Trending
What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...
Simply Wall St. · 05/13 14:04
More
No Data
Learn about the latest financial forecast of DGX. Analyze the recent business situations of Quest Diagnostics Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

16.67%Strong Buy
22.22%Buy
61.11%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average DGX stock price target is 151.86 with a high estimate of 185.00 and a low estimate of 129.00.
High185.00
Average151.86
Low129.00
Current 141.03
EPS
Actual
Estimate
0.991.982.973.96
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 1.14K
Institutional Holdings: 122.73M
% Owned: 104.57%
Shares Outstanding: 117.37M
TypeInstitutionsShares
Increased
256
7.06M
New
82
660.27K
Decreased
311
6.31M
Sold Out
123
813.90K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.72%
Healthcare Providers & Services
+0.26%
Key Executives
Chairman/President/Chief Executive Officer/Director
Stephen Rusckowski
Chief Executive Officer
James Davis
Chief Financial Officer/Executive Vice President
Mark Guinan
Senior Vice President/General Counsel
Michael Prevoznik
Senior Vice President
Mark Delaney
Senior Vice President
Catherine Doherty
Senior Vice President
Carrie Manner
Senior Vice President
Patrick Plewman
Vice President
Richard Adams
Lead Director/Independent Director
Timothy Ring
Independent Director
Tracey Doi
Independent Director
Vicky Gregg
Independent Director
Wright Lassiter
Independent Director
Timothy Main
Independent Director
Denise Morrison
Independent Director
Gary Pfeiffer
Independent Director
Gail Wilensky
No Data
No Data
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates under two segments: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services develops and delivers diagnostic testing information and services, providing insights that enables a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, and other brands, such as AmeriPath, Dermpath Diagnostics, ExamOne, Quanum. It also helps in delivering diagnostic insights for COVID-19 and a range of other medical conditions for communities in South Florida.

Webull offers kinds of Quest Diagnostics Inc stock information, including NYSE:DGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DGX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DGX stock methods without spending real money on the virtual paper trading platform.